Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Videos
WCLC 2016 - Lung Cancer
WCLC 2016 – Lung Cancer
Filter by Topic
Interview with the Innovators
Webinars
2018 AONN+ Midyear Conference
2018 ASCO Insights
AVBCC
AVBCC 2016
Payer-Provider
Personalized Medicine
Pricing
SABCS 2017
EHA 2016
WCLC 2016 - Lung Cancer
View All Videos ›
Challenges in Managing Toxicities
FEATURING:
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Watch Video
My Practice: Roles and Responsibilities
FEATURING:
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Watch Video
Immunotherapies and Lung Cancer
FEATURING:
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Watch Video
Choosing the Right Therapy for Patients with NSCLC
FEATURING:
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Watch Video
Differences in NSCLC Patient Populations
FEATURING:
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Watch Video
ALK Gene Rearrangement and PD-L1 Expression
FEATURING:
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Watch Video
A Look at PD-1 and PD-L1 Inhibitors
FEATURING:
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Watch Video
Shifts in Lung Cancer Treatment
FEATURING:
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Watch Video
Common Presenting Factors for NSCLC
FEATURING:
Dr. Edward Garon
Lung Cancer
,
WCLC 2016 – Lung Cancer
Watch Video
Page 1 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma